Trial Profile
Open Label Phase II Clinical Trial of Myoma Immunotherapy
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 05 May 2020
Price :
$35
*
At a glance
- Drugs V-Myoma (Primary)
- Indications Uterine leiomyoma
- Focus Therapeutic Use
- Sponsors Immunitor
- 15 Jun 2018 New trial record